“In sharp contrast to other illnesses and despite many efforts, huge expense and hundreds of clinical trials, no new treatments have been approved in the past 16 years. The emphasis has been on drugs targeting beta-amyloid proteins, which clump into plaques in the brains of afflicted people. Unfortunately, these approaches have not yet yielded the results we hoped for.”
Read the full story at scientificamerican.com
Better Biomarkers Could Help Us Treat Alzheimer’s | Scientific American
More from ResearchMore posts in Research »
- A possible blood test for early-stage Alzheimer’s disease | Medical Xpress
- Blood Biomarkers Plus Gene Status Predict Cognitive Decline : Neurology Today
- Early Detection of Alzheimer’s Prior to Onset of Symptoms Now Possible | Science Times
- We Need New Ideas for Fighting Alzheimer’s | Scientific American
- Immune view offers clues to early Alzheimer’s